Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Cubist Pharmaceuticals LLC
ClinicalTrials.gov Identifier:
NCT00388401
First received: October 13, 2006
Last updated: July 16, 2015
Last verified: October 2008